Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D Study

Medicine and Dentistry

• Adverse Event 20%
• Anti-Human Immunodeficiency Virus 20%
• Antiretroviral Therapy 100%
• Cell Count 40%
• Drug Use 20%
• Hepatitis B 20%
• Hepatitis B Virus 20%
• Hepatitis C 20%
• Hepatitis C Virus 20%
• Hepatitis Virus 20%
• Human Immunodeficiency Virus 100%
• Immune Deficiency 20%
• Liver Disease 20%
• Mixed Infection 20%
• Patient Characteristics 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 33%
• Anti-Human Immunodeficiency Virus 33%
• Hepatitis B 33%
• Hepatitis B Virus 33%
• Hepatitis C 33%
• Hepatitis C Virus 33%
• HIV 100%
• Immune Deficiency 33%
• Liver Disease 33%
• Mixed Infection 33%
• Virus Hepatitis 33%